Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic
- Citation:
- Lancet Oncol vol 23 (2) 195-7
- Year:
- 2022
- Type:
- Manuscript
- Funding:
- AFT
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 11
- Parents:
- None
- Children:
- None
- Pharmas:
- Pfizer
- Grants:
- Corr. Author:
- Authors:
- Georg Pfeiler Angela DeMichele Amylou C Dueck Christian Fesl Michael Gnant Erica L Mayer
- Networks:
- LAPS-MA036, LAPS-MN026
- Study
- AFT-05
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: